Catalog No.
KAC90703
Description
PRINCIPLE OF THE ASSAY This assay employs the quantitative sandwich enzyme immunoassay technique. Ocrelizumab has been pre-coated onto a microplate. Samples or standards are pipetted into microwells and Anti-Ocrelizumab will be captured by immobilized Ocrelizumab. After washing away any unbound substances, a biotin-labeled Ocrelizumab is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-Ocrelizumab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications
Used for the quantitative determination of Anti-Ocrelizumab concentration in serum and plasma.
Sample type
Plasma, Serum
Range
156.25 - 10,000 ng/mL
Sensitivity
121.24 ng/mL
Precision
Intra-Assay Precision (Precision within an assay): <10%
Three samples of known concentration were tested sixteen times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): <15%
Three samples of known concentration were tested in twenty four separate assays to assess inter-assay precision.
Stability and Storage
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
For research use only. Not for human or drug use.
